Cognitive–Emotional Functioning in Substance Use Disorder: Differences by MoCA-Based Mild Cognitive Impairment

Main Article Content

Diego-Oswaldo Camacho-Vega
Rosa Linda Martínez Hampl
Luis Villalobos-Gallegos
María Guadalupe Delgadillo Ramos
Salvador Trejo García

Abstract

Introduction: addiction is a chronic yet treatable condition characterized by alterations in brain circuits, cognitive deficits, and emotional dysregulation, which increase relapse risk and complicate treatment outcomes. Mild cognitive impairment (MCI) may represent an additional vulnerability affecting the coordination of inhibitory control and emotional processes; however, its role in chronic drug users remains understudied.

Objective: to compare inhibitory control, emotional interference, and emotional regulation between chronic drug users with and without MCI, and to examine associations among cognitive, emotional, and behavioral measures.

Method: a cross-sectional comparative study was conducted with 80 male drug users recruited from residential treatment centers. Participants met DSM-5 criteria for substance use disorder, reported polysubstance use, and maintained at least six weeks of abstinence. Cognitive status was assessed using the Montreal Cognitive Assessment. Inhibitory control was measured with a Go/No-Go task, and emotional regulation with the Emotional Stroop Test and the Difficulties in Emotion Regulation Scale. Analyses included nonparametric comparisons, partial correlations controlling for age, and False Discovery Rate correction.

Results: participants had a mean age of 34.1 years (SD = 10), and 48.8% met criteria for MCI. No sociodemographic differences were observed between groups. The MCI group showed greater variability in inhibitory control and weaker, less consistent associations between cognitive performance and emotional interference measures. In contrast, the non-MCI group exhibited more stable and distributed cognitive–emotional associations. No significant differences were found in self-reported emotional regulation.

Discussion and conclusions: findings suggest that MCI is associated less with global deficits and more with reduced stability and integration of cognitive–emotional functioning. Considering cognitive status may improve interventions targeting coordinated cognitive control and emotional regulation in addiction treatment.

Keywords:
mild cognitive impairment ,   inhibitory control ,   emotional regulation ,   substance-related disorders
Published: Jun 5, 2026

Article Details

How to Cite
Camacho-Vega, D.-O., Martínez Hampl, R. L., Villalobos-Gallegos, L., Delgadillo Ramos, M. G., & Trejo García, S. (2026). Cognitive–Emotional Functioning in Substance Use Disorder: Differences by MoCA-Based Mild Cognitive Impairment. Revista Internacional De Investigación En Adicciones, 12(1). https://doi.org/10.28931/riiad.2026.424
Section
Original Articles

References

Aguilar-Navarro, S. G., Mimenza-Alvarado, A. J., Palacios-García, A. A., Samudio-Cruz, A., Gutiérrez-Gutiérrez, L. A., & Ávila-Funes, J. A. (2018). Validez y confiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje del deterioro cognoscitivo en México. Revista Colombiana de Psiquiatría, 47(4), 237–243. https://doi.org/10.1016/j.rcp.2017.05.003

American Psychiatric Association (Ed.). (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). American Psychiatric Association.

American Psychiatric Association (Ed.). (2022). Diagnostic and statistical manual of mental disorders: DSM-5-TRTM (5th ed., text revision). American Psychiatric Association Publishing.

Bandeira, M., Cavalcanti, M. K., Cordeiro, S., Soares, J. W. J., & Duarte, M. (2021). Executive functions and emotion regulation in substance use disorder. Jornal Brasileiro De Psiquiatria, 70(3), 236–244. https://doi.org/10.1590/0047-2085000000331

Bechara, A., & Damasio, H. (2002). Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia, 40(10), 1675–1689. https://doi.org/10.1016/S0028-3932(02)00015-5

Beaton, D. E., Bombardier, C., Guillemin, F., & Ferraz, M. B.. (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine, 25, 3186–3191. https://doi.org/10.1097/00007632-200012150-00014

Becoña, E. (2007). Bases psicológicas de la prevención del consumo de drogas. Papeles del Psicólogo, 28(1), 11–20. https://www.papelesdelpsicologo.es/pdf/1424.pdf

Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x

Brand, M., Wegmann, E., Stark, R., Müller, A., Wölfling, K., Robbins, T. W., & Potenza, M. N. (2019). The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors. Neuroscience & Biobehavioral Reviews, 104, 1–10. https://doi.org/10.1016/j.neubiorev.2019.06.032

Brislin, R. W.. (1970). Back-translation for cross-cultural research. Journal of Cross-Cultural Psychology, 1, 185–216. https://doi.org/10.1177/135910457000100301

Carranza-Plancarte, J., Navarro-Contreras, G., Correa-Romero, F., & González-Torres, M. (2022). Validación psicométrica de la escala de dificultades en la regulación emocional DERS para adultos michoacanos. Revista de Educación y Desarrollo, 61, 39–48. https://www.cucs.udg.mx/revistas/edu_desarrollo/anteriores/61/61_Carranza.pdf

Eliorriaga-Santiago, S., Montes-Rojas, J., Medina-Gutierrez, M., & Ortiz-Becerra, A. (2017). Estandarización Mexicana del Test Stroop: Datos Normativos. Universidad Latinoamericana.

Enoch, M.-A. (2012). The Influence of Gene–Environment Interactions on the Development of Alcoholism and Drug Dependence. Current Psychiatry Reports, 14(2), 150–158. https://doi.org/10.1007/s11920-011-0252-9

Ferguson, C. J. (2009). An Effect Size Primer: A Guide for Clinicians and Researchers. Professional Psychology: Research and Practice, 40(5), 532–538. https://doi.org/10.1037/a0015808

Gao, Y., Zaninotto, P., & Steptoe, A. (2026). Associations of self- and informant-reported functional impairment with cognitive performance and incident dementia. The Journal of Prevention of Alzheimer’s Disease, 13(3). https://doi.org/10.1016/j.tjpad.2026.100482

Heilig, M., MacKillop, J., Martinez, D., Rehm, J., Leggio, L., & Vanderschuren, L. J. M. J. (2021). Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology, 46(10), 1715–1723. https://doi.org/10.1038/s41386-020-00950-y

Isaac, L., Vrijsen, J. N., Eling, P., Van Oostrom, I., Speckens, A., & Becker, E. S. (2012). Verbal and facial-emotional Stroop tasks reveal specific attentional interferences in sad mood. Brain and Behavior, 2(1), 74–83. https://doi.org/10.1002/brb3.38

Lavender, J. M., Tull, M. T., DiLillo, D., Messman-Moore, T., & Gratz, K. L. (2017). Development and Validation of a State-Based Measure of Emotion Dysregulation: The State Difficulties in Emotion Regulation Scale (S-DERS). Assessment, 24(2), 197–209. https://doi.org/10.1177/1073191115601218

Makmee, P., & Wongupparaj, P. (2022). Virtual Reality-based Cognitive Intervention for Enhancing Executive Functions in Community-dwelling Older Adults. Psychosocial Intervention, 31(3), 133–144. https://doi.org/10.5093/pi2022a10

Melugin, P. R., Nolan, S. O., & Siciliano, C. A. (2021). Bidirectional causality between addiction and cognitive deficits. International Review of Neurobiology, 157, 371–407. https://doi.org/10.1016/bs.irn.2020.11.001

Mueller, S. T., & Piper, B. J. (2014). The Psychology Experiment Building Language (PEBL) and PEBL Test Battery. Journal of Neuroscience Methods, 222, 250–259. https://doi.org/10.1016/j.jneumeth.2013.10.024

Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x

Rae, G. (1985). Quade’s nonparametric analysis of covariance by matching. Behavior Research Methods, Instruments, & Computers, 17(3), 421–422. https://doi.org/10.3758/BF03200959

Ramey, T., & Regier, P. S. (2019). Cognitive impairment in substance use disorders. CNS Spectrums, 24(1), 102–113. https://doi.org/10.1017/S1092852918001426

Secretaría de Salud, Comisión Nacional contra las Adicciones, & Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. (2017). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016–2017: Reporte de drogas. Secretaría de Salud. https://encuestas.insp.mx/repositorio/encuestas/ENCODAT2016/doctos/informes/reporte_encodat_drogas_2016_2017.pdf

Smith, P. M., & Waterman, M.. Processing bias for aggression words in forensic and nonforensic samples. Cognition & Emotion, 17, 751–765. https://doi.org/10.1080/02699930302281

Stellern, J., Xiao, K. B., Grennell, E., Sanches, M., Gowin, J. L., & Sloan, M. E. (2022). Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction, 118(1), 30–47. https://doi.org/10.1111/add.16001

Strauss, G. P., Allen, D. N., Jorgensen, M. L., & Cramer, S. L. (2005). Test-Retest Reliability of Standard and Emotional Stroop Tasks: An Investigation of Color-Word and Picture-Word Versions. Assessment, 12(3), 330–337. https://doi.org/10.1177/1073191105276375

Sturm, V. E., Yokoyama, J. S., Seeley, W. W., Kramer, J. H., Miller, B. L., & Rankin, K. P. (2013). Heightened emotional contagion in mild cognitive impairment and Alzheimer’s disease is associated with temporal lobe degeneration. Proceedings of the National Academy of Sciences, 110(24), 9944–9949. https://doi.org/10.1073/pnas.1301119110

Toledo-Fernández, A., Marín-Navarrete, R., Villalobos-Gallegos, L., Salvador-Cruz, J., Benjet, C., & Roncero, C. (2020). Exploring the prevalence of substance-induced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairment. Psychiatry Research, 288. https://doi.org/10.1016/j.psychres.2020.112944

Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. New England Journal of Medicine, 374(4), 363–371. https://doi.org/10.1056/NEJMra1511480

Williams, J. M. G., Mathews, A., & MacLeod, C. (1996). The emotional Stroop task and psychopathology. Psychological Bulletin, 120(1), 3–24. https://doi.org/10.1037/0033-2909.120.1.3